What is Ipsen known for?
Ipsen is a global biopharmaceutical group dedicated to improving lives and health outcomes through innovative medicines in Oncology, Neuroscience and Rare Disease. We also have a well-established and successful Consumer Healthcare business.
Is Ipsen a big company?
Ipsen is a French pharmaceutical company headquartered in Paris, France. It is specialized in oncology, neuroscience and rare diseases. It is publicly traded on the Euronext Paris as part of the SBF 120 index (2005)….Ipsen.
| Type | Public |
|---|---|
| Website | www.ipsen.com |
Where is Ipsen located?
Cambridge, Massachusetts
Global Biopharmaceutical Company, Ipsen Announces New Headquarters for North America will be located in Cambridge, Massachusetts – Ipsen US.
What drugs does Ipsen make?
We offer a number of important solutions for patients with difficult-to-treat cancers:
- Cabometyx® (cabozantinib)
- Cometriq® (cabozantinib)
- Decapeptyl® (triptorelin pamoate)
- Onivyde® (irinotecan liposome injection)
- Somatuline® (lanreotide)
- Xermelo® (telotristat ethyl)
When was Ipsen founded?
1929
Ipsen/Founded
History Since it was founded in 1929, by Henri Beaufour, Ipsen has developed, and made available to patients, a number of products in Oncology, Neuroscience, Rare Diseases and Consumer Healthcare.
What kind of company is Ipsen Pharmaceutical Company?
From Wikipedia, the free encyclopedia Ipsen is a French pharmaceutical company headquartered in Paris, France. It is specialized in three therapeutic areas: oncology, neuroscience and rare diseases. It is publicly traded on the Euronext Paris as part of the SBF 120 index.
What is Ipsen and what does it do for patients?
Ipsen is a leading biopharmaceutical group dedicated to prolonging and improving lives and health outcomes through innovative medicines in oncology, neuroscience and rare disease. Patients and society are at the core of our mission.
Who is the executive vice president of Ipsen?
David earned his BA in Business Administration and MBA from the University of St. Gallen, Switzerland. Bartosz (Bartek) Bednarz, DDS, is Executive Vice President, Head of Global Product and Portfolio Strategy at Ipsen, which covers Global Franchises, Global Value and Access, Global Policy and Global Strategic Business Excellence.
When did Ipsen start to treat kidney cancer?
We have been active in this area since 1986, branching out from a strong foundation in neuroendocrine tumors (NETs), kidney, liver, pancreatic, prostate, bladder, and breast cancers.